Quincy Bioscience
TINA.org investigated Quincy Bioscience’s marketing of its brain supplement Prevagen, and was involved as amicus curiae in two separate lawsuits filed against the company. To read more about those efforts, click here.
Brands
Featured
Prevagen Memory Study Falls Short
TINA.org, AARP and others file legal brief urging court to reverse dismissal of Prevagen case.
The Latest
April Fools: How Some Companies Prank Consumers with Common Marketing Terms
These definitions are a joke.
Jury Hands Down a Verdict in Prevagen Deceptive Marketing Case
Verdict comes nine years after TINA.org alerted regulator to supplement’s unsubstantiated health claims.
Will Prevagen’s Deceptive Advertising Ever End?
Eight years after TINA.org alerted regulators, supplement ads continue to convey deceptive and misleading memory improvement claims.
Prevagen: The Dismal Facts & Figures that Led to TINA.org’s Objection
Pending class-action settlement leaves consumers behind.
FTC Brain Claims Cases Since 1995
Since 1995, the FTC has brought nearly 70 actions over deceptive brain claims.
Five Reasons the BBB Shouldn’t Be Your Only Stop
Researching a company shouldn’t be one-stop shopping.
How Amazon Promotes, Profits from Deceptively Marketed Brain Supplements
The largest retailer in the world isn’t just turning a blind eye to the deceptive marketing of these products.
5 Ad Trends to Be Wary of in 2020
CGI influencers are here.
Thinking about Taking a Supplement for Brain Health? Not So Fast
Brain experts say save your money.
Comment at FDA Public Meeting on Dietary Supplements
Comment made by TINA.org executive director, Bonnie Patten at the FDA’s public meeting on Responsible Innovation in Dietary Supplements held on May 16, 2019. Thank you for the opportunity to…
Class-Action Tracker
Prevagen
False advertising class-action lawsuits filed against Quincy Bioscience regarding its marketing of Prevagen